MedPath

Efficacy of silver zinc sulfadiazine cream containing silk sericin for the treatment of burn wounds

Not Applicable
Completed
Conditions
Second degree burn wounds
Injury, Occupational Diseases, Poisoning
Burn of second degree, body region unspecified
Registration Number
ISRCTN79764413
Lead Sponsor
ational Research Council (Thailand)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
16
Inclusion Criteria

1. 15-60 years of age
2. Second degree burn wounds covering no less than 15% of the total body surface area (TBSA) with no wound infection
3. Patients were to stay at the hospital until the wounds were completely healed

Exclusion Criteria

1. Patients with history of allergy to sulfonamides, sericin, or any of the other ingredients in the formulation
2. Patients who had active diabetes mellitus, chronic obstructive pulmonary disease, psychological problems, dementia, malnutrition or immunodeficiency
3. Patients who experienced abnormal liver or renal function tests prior to enrollment
4. Patients with cancer or receiving chemotherapy and those who were pregnant or breastfeeding
5. Patients who show no response to the treatment, were not willing to continue with the study, or when the physician opined that treatment was no longer needed

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath